Romina: A powerful strawberry with in vitro efficacy against uterine leiomyoma cells

J Cell Physiol. 2019 May;234(5):7622-7633. doi: 10.1002/jcp.27524. Epub 2018 Oct 14.

Abstract

Uterine leiom yomas are benign tumors highly prevalent in reproductive women. In thecurrent study, initially, we aimed to screen five different strawberry cultivars (Alba, Clery, Portola, Tecla, and Romina) to identify efficient cultivars in terms of phytochemical characterization and biological properties by measuring phenolic and anthocyanin content as well as antioxidant capacity, and by measuring apoptotic rate and reactive oxygen species (ROS) production in uterine leiomyoma cells. Next, we focused on the most efficient ones, cultivar Alba (A) and Romina (R) as well as Romina anthocyanin (RA) fraction for their ability to regulate oxidative phosphorylation (oxygen consumption rate [OCR]) glycolysis (extracellular acidification rate [ECAR]), and also fibrosis. Leiomyoma and myometrial cells were treated with a methanolic extract of A and R (250 μg/ml) or with RA (50 μg/ml) for 48 hr to measure OCR and ECAR, as well as gene expression associated with fibrosis. In the leiomyoma cells, RA was more effective in inducing apoptosis and increasing intracellular ROS levels, followed by R and A. In myometrial cells, all strawberry treatments increased the cellular viability and decreased ROS concentrations. Leiomyoma cells showed also a significant decrease in ECAR, especially after RA treatment, while OCR was slightly increased in both myometrial and leiomyoma cells. R and RA treatment significantly decreased collagen 1A1, fibronectin, versican, and activin A messenger RNA expression in leiomyoma cells. In conclusion, this study suggests that Romina, or its anthocyanin fraction, can be developed as a therapeutic and/or preventive agent for uterine leiomyomas, confirming the healthy effects exerted by these fruits and their bioactive compounds.

Keywords: Romina; apoptosis; cultivars; fibrosis; glycolysis; strawberry; uterine leiomyoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activins / pharmacology
  • Antioxidants / metabolism
  • Apoptosis / drug effects
  • Cell Survival / drug effects
  • Collagen Type I / metabolism
  • Female
  • Fibronectins / metabolism
  • Fibrosis / drug therapy
  • Fibrosis / metabolism
  • Fragaria / chemistry*
  • Gene Expression / drug effects
  • Glycolysis / drug effects
  • Humans
  • Leiomyoma / drug therapy*
  • Leiomyoma / metabolism
  • Oxidative Phosphorylation / drug effects
  • Plant Preparations / pharmacology*
  • Reactive Oxygen Species / metabolism
  • Tumor Cells, Cultured
  • Uterine Neoplasms / drug therapy*
  • Uterine Neoplasms / metabolism
  • Versicans / pharmacology

Substances

  • Antioxidants
  • Collagen Type I
  • Fibronectins
  • Plant Preparations
  • Reactive Oxygen Species
  • activin A
  • Activins
  • Versicans